日科化学
(300214)
| 流通市值：26.82亿 | | | 总市值：30.98亿 |
| 流通股本：4.03亿 | | | 总股本：4.65亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 931,593,350.81 | 3,518,393,513.02 | 2,414,682,357.16 | 1,428,100,103.76 |
| 营业收入 | 931,593,350.81 | 3,518,393,513.02 | 2,414,682,357.16 | 1,428,100,103.76 |
| 二、营业总成本 | 951,530,143.58 | 3,543,701,641.22 | 2,454,490,785.67 | 1,462,750,913.75 |
| 营业成本 | 888,955,004.77 | 3,327,252,433.83 | 2,309,964,442.2 | 1,371,377,783.07 |
| 税金及附加 | 6,246,862.04 | 23,343,245.77 | 16,906,819.39 | 10,089,806.91 |
| 销售费用 | 8,973,054.74 | 36,446,004.39 | 24,908,679.34 | 15,976,155.35 |
| 管理费用 | 26,996,151.36 | 86,000,397.3 | 62,197,098.08 | 41,313,720.29 |
| 研发费用 | 10,497,948.64 | 40,361,367.62 | 18,561,265.46 | 13,976,097.03 |
| 财务费用 | 9,861,122.03 | 30,298,192.31 | 21,952,481.2 | 10,017,351.1 |
| 其中:利息费用 | 11,597,262.49 | 35,816,983.52 | 22,917,822.99 | 13,028,527.5 |
| 其中:利息收入 | 552,012.9 | 1,731,486.47 | 623,747.21 | 628,871.65 |
| 加:公允价值变动收益 | 0 | 0 | 0 | 0 |
| 加:投资收益 | 603,331.55 | 3,839,107.06 | 4,820,166.34 | 2,286,041.38 |
| 净敞口套期收益 | 0 | 0 | 0 | 0 |
| 资产处置收益 | 0 | -237,640.19 | 186,752.54 | 182,047.6 |
| 资产减值损失(新) | 8,748,036.38 | -53,591,107.99 | -2,694,600.48 | -2,694,600.48 |
| 信用减值损失(新) | -3,452,999.7 | -20,746,604.99 | -8,012,551.29 | -4,706,969.21 |
| 其他收益 | 2,587,110.4 | 6,437,819.23 | 769,634.22 | 664,492.86 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -11,451,314.14 | -89,606,555.08 | -44,739,027.18 | -38,919,797.84 |
| 加:营业外收入 | 33,451.52 | 821,545.33 | 815,833.73 | 658,341.07 |
| 减:营业外支出 | 99,241.82 | 2,200,376.32 | 2,055,260.91 | 875,099.14 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -11,517,104.44 | -90,985,386.07 | -45,978,454.36 | -39,136,555.91 |
| 减:所得税费用 | -946,358.35 | -23,464,577.11 | 8,120,403.72 | 3,062,253.94 |
| 六、净利润 | -10,570,746.09 | -67,520,808.96 | -54,098,858.08 | -42,198,809.85 |
| 持续经营净利润 | -10,570,746.09 | -67,520,808.96 | -54,098,858.08 | -42,198,809.85 |
| 归属于母公司股东的净利润 | -8,634,199.21 | -68,161,215.83 | -52,331,549.94 | -42,321,071.94 |
| 少数股东损益 | -1,936,546.88 | 640,406.87 | -1,767,308.14 | 122,262.09 |
| (一)基本每股收益 | -0.02 | -0.15 | -0.11 | -0.09 |
| (二)稀释每股收益 | -0.02 | -0.15 | -0.11 | -0.09 |
| 九、综合收益总额 | -10,570,746.09 | -67,520,808.96 | -54,098,858.08 | -42,198,809.85 |
| 归属于母公司股东的综合收益总额 | -8,634,199.21 | -68,161,215.83 | -52,331,549.94 | -42,321,071.94 |
| 归属于少数股东的综合收益总额 | -1,936,546.88 | 640,406.87 | -1,767,308.14 | 122,262.09 |
| 公告日期 | 2025-04-26 | 2025-04-18 | 2024-10-23 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |